Atlas Trials

Functional Improvement of Progenitor Cells and Endothelial Function by Vildagliptin in Diabetes Mellitus (FINNjA-DM).

Clinical trial NCT00936234 · WITHDRAWN

Trial details

NCT number
NCT00936234
Sponsor
Johann Wolfgang Goethe University Hospital
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors
Start date
2009-07-01
Primary completion
2011-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.